SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-368374
Filing Date
2015-11-05
Accepted
2015-11-05 16:31:32
Documents
11
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d24660d10q.htm 10-Q 387919
2 EX-10.1 d24660dex101.htm EX-10.1 59609
3 EX-31.1 d24660dex311.htm EX-31.1 5991
4 EX-31.2 d24660dex312.htm EX-31.2 6035
5 EX-32 d24660dex32.htm EX-32 4049
  Complete submission text file 0001193125-15-368374.txt   2636133

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT itci-20150930.xml EX-101.INS 499138
7 XBRL TAXONOMY EXTENSION SCHEMA itci-20150930.xsd EX-101.SCH 26781
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE itci-20150930_cal.xml EX-101.CAL 39208
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE itci-20150930_def.xml EX-101.DEF 84395
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE itci-20150930_lab.xml EX-101.LAB 251412
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE itci-20150930_pre.xml EX-101.PRE 170642
Mailing Address 430 EAST 29TH STREET NEW YORK NY 10016
Business Address 430 EAST 29TH STREET NEW YORK NY 10016 212-923-3344
Intra-Cellular Therapies, Inc. (Filer) CIK: 0001567514 (see all company filings)

IRS No.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36274 | Film No.: 151201170
SIC: 2834 Pharmaceutical Preparations